These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21537073)

  • 21. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.
    Zhang H; Pan CQ; Pang Q; Tian R; Yan M; Liu X
    Hepatology; 2014 Aug; 60(2):468-76. PubMed ID: 25187919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus.
    Yu M; Jiang Q; Ji Y; Jiang H; Wu K; Ju L; Tang X; Wu M
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2211-8. PubMed ID: 22314409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: A meta-analysis.
    Song J; Yang F; Wang S; Tikande S; Deng Y; Tang W; Cao G
    J Viral Hepat; 2019 Mar; 26(3):397-406. PubMed ID: 30417469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.
    ; Dionne-Odom J; Tita AT; Silverman NS
    Am J Obstet Gynecol; 2016 Jan; 214(1):6-14. PubMed ID: 26454123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review.
    Tavakolpour S; Darvishi M; Mirsafaei HS; Ghasemiadl M
    Infect Dis (Lond); 2018 Feb; 50(2):95-106. PubMed ID: 29020844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of lamivudine treatment for chronic hepatitis B in early pregnancy.
    Yi W; Liu M; Cai HD
    World J Gastroenterol; 2012 Dec; 18(45):6645-50. PubMed ID: 23236240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testing.
    Thilakanathan C; Wark G; Maley M; Davison S; Lawler J; Lee A; Shackel N; Nguyen V; Jackson K; Glass A; Locarnini SA; Levy MT
    Liver Int; 2018 Jul; 38(7):1212-1219. PubMed ID: 29532580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus.
    Chen HL; Lee CN; Chang CH; Ni YH; Shyu MK; Chen SM; Hu JJ; Lin HH; Zhao LL; Mu SC; Lai MW; Lee CL; Lin HM; Tsai MS; Hsu JJ; Chen DS; Chan KA; Chang MH; ;
    Hepatology; 2015 Aug; 62(2):375-86. PubMed ID: 25851052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B.
    Pan CQ; Han GR; Jiang HX; Zhao W; Cao MK; Wang CM; Yue X; Wang GJ
    Clin Gastroenterol Hepatol; 2012 May; 10(5):520-6. PubMed ID: 22343511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations.
    Ayres A; Yuen L; Jackson KM; Manoharan S; Glass A; Maley M; Yoo W; Hong SP; Kim SO; Luciani F; Bowden DS; Bayliss J; Levy MT; Locarnini SA
    J Viral Hepat; 2014 Nov; 21(11):809-17. PubMed ID: 24329944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.
    Xu WM; Cui YT; Wang L; Yang H; Liang ZQ; Li XM; Zhang SL; Qiao FY; Campbell F; Chang CN; Gardner S; Atkins M
    J Viral Hepat; 2009 Feb; 16(2):94-103. PubMed ID: 19175878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical observation of telbivudine's antiviral efficacy and protection against mother-to-infant transmission of chronic hepatitis B during the first trimester of pregnancy].
    Chen C; Tu X; Cheng Q; Chen F; Dai Y; Gong F; Lin X
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jan; 23(1):9-12. PubMed ID: 25751379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus].
    Han GR; Jiang HX; Wang GJ; Yue X; Wang CM; Kan NY; Wu MM
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):201-5. PubMed ID: 22475140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: a national cohort study.
    Ding Y; Cao L; Zhu L; Huang Y; Lin C; Wang Y; Liu Y; Sheng Q; Wang S; Fan J; Chen R; Gan W; Chen B; Pan CQ
    Aliment Pharmacol Ther; 2020 Oct; 52(8):1377-1386. PubMed ID: 32852100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
    Yin YZ; Zhou J; Zhang PZ; Hou HY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of infectivity in chronic hepatitis B virus carriers among healthcare providers and pregnant women by antiviral therapy.
    Gerlich WH
    Intervirology; 2014; 57(3-4):202-11. PubMed ID: 25034489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine.
    Safadi R; Xie Q; Chen Y; Yin YK; Wei L; Hwang SG; Zuckerman E; Jia JD; Lopez P
    Liver Int; 2011 May; 31(5):667-75. PubMed ID: 21040410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
    Sellier PO; Maylin S; Berçot B; Chopin D; Lopes A; Simoneau G; Evans J; Delcey V; Bénifla JL; Simon F; Bergmann JF
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):259-263. PubMed ID: 27879486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of hepatitis B in pregnancy: weighing the options.
    Tran TT
    Cleve Clin J Med; 2009 May; 76 Suppl 3():S25-9. PubMed ID: 19465706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virological response to antiviral therapy at week 12 indicates a great reduction of intrahepatic hepatitis B virus DNA and cccDNA in HBeAg-positive chronic hepatitis B patients.
    Lu HY; Zhuang LW; Yu YY; Si CW
    J Viral Hepat; 2010 Mar; 17 Suppl 1():59-65. PubMed ID: 20586935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.